Data layers Raw facts Calculated Model prediction AI interpretation

Company Overview

Stock NameAngelalign
Stock Code06699
Company Full NameTo be extracted
IndustryHealthcare
Principal Activities我們是中國領先的隱形矯治解決方案提供商,為牙科醫生提供自研的數字化正畸解決方案-時代天使隱形矯治系統,包括數字化輔助案例評估支持及矯治方案設計服務、定制可拆裝的隱形矯治器及雲服務平台iOrtho。
Listing Date2021-06-16
Listing Rules EraOld Rules
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)中國上海市 楊浦區 政立路500號 創智天地企業中心7號樓7樓
Business Address (Hong Kong)香港 皇后大道東183號 合和中心54樓
Place of IncorporationTo be extracted
Listing MethodTo be extracted
Listing BoardMain Board
Websitewww.angelalign.com
Share Registrar卓佳证券登记有限公司 (Tricor Investor Services Limited)
Registrar Contact(852)2980 1333
A-Share/US Dual ListingNo

Offering Information

Offering Mechanism Mechanism A
Offer PriceHK$ 173.00 / shares
Offer Price RangeFinal offer price only, no range
Lot Size200 shares
Entry ThresholdHK$ 34,600
Par ValueTo be extracted
Offer Period2021-06-03 to 2021-06-08
Global Offering Shares16,829,600 shares
HK Public Offer Shares (Initial)1,683,000 shares (10.0%)
Public Offer Lots (Initial)8,415lots (Pool A4,207lots,Pool B4,208lots)
International Placing Shares (Initial)15,146,600 shares (90.0%)
Offer Ratio~10.0%
Total Shares Post-IPO165,807,100 shares
Greenshoe (Over-allotment Option)Yes
Stabilizing Manager (Greenshoe)To be extracted
Cornerstone ShareNo cornerstone investors
Clawback TiersTo be extracted
Reallocation OptionYes
Total Global Offering SizeHK$ 2,911,520,800

Subscription Tiers

Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.

Pool A
Lots SubscribedShares SubscribedSubscription Amount (HKD)
1 lots 200 HK$ 34,600
5 lots 1,000 HK$ 173,000
10 lots 2,000 HK$ 346,000
15 lots 3,000 HK$ 519,000
20 lots 4,000 HK$ 692,000
25 lots 5,000 HK$ 865,000
30 lots 6,000 HK$ 1,038,000
35 lots 7,000 HK$ 1,211,000
40 lots 8,000 HK$ 1,384,000
45 lots 9,000 HK$ 1,557,000
50 lots 10,000 HK$ 1,730,000
75 lots 15,000 HK$ 2,595,000
100 lots 20,000 HK$ 3,460,000
102 lots 20,461 HK$ 3,539,753
125 lots 25,000 HK$ 4,325,000
Pool B
Lots SubscribedShares SubscribedSubscription Amount (HKD)
150 lots 30,000 HK$ 5,190,000
150 lots 30,099 HK$ 5,207,127
175 lots 35,000 HK$ 6,055,000
192 lots 38,571 HK$ 6,672,783
200 lots 40,000 HK$ 6,920,000
225 lots 45,000 HK$ 7,785,000
250 lots 50,000 HK$ 8,650,000
300 lots 60,000 HK$ 10,380,000
350 lots 70,000 HK$ 12,110,000
400 lots 80,000 HK$ 13,840,000
450 lots 90,000 HK$ 15,570,000
500 lots 100,000 HK$ 17,300,000
750 lots 150,000 HK$ 25,950,000
1,000 lots 200,000 HK$ 34,600,000
1,250 lots 250,000 HK$ 43,250,000
1,500 lots 300,000 HK$ 51,900,000
1,750 lots 350,000 HK$ 60,550,000
2,000 lots 400,000 HK$ 69,200,000
2,250 lots 450,000 HK$ 77,850,000
2,500 lots 500,000 HK$ 86,500,000
3,000 lots 600,000 HK$ 103,800,000
3,500 lots 700,000 HK$ 121,100,000
4,000 lots 800,000 HK$ 138,400,000
4,207 lots 841,400 HK$ 145,562,200

Stock Connect Inclusion Analysis

Avg Daily HK Mkt Cap HK$ 13.53B
Analysis Result Already included in Stock Connect (both)

Valuation & Financials

Market Cap (at Offer Price)HK$ 26,529,136,000
Pre-IPO Valuation (Last Round)Not disclosed
P/E RatioNot disclosed
Profit/Loss Status盈利約人民幣150.9百萬元
Period-End Cash BalanceTo be extracted
Listing Expenses~HK$ 179,736,000
Listing Expenses / Funds Raised~6.17%
Total Pre-IPO InvestmentTo be extracted

Financial Data

Unit: '000 RMB
Income Statement
Item 201820192020
Revenue 488,483645,898816,528
Cost of sales -176,765-228,756-241,479
Gross profit 311,718417,142575,049
Other income and gains, net 4,6088,80422,625
Selling and distribution expenses -81,439-122,645-148,835
Administrative expenses -107,702-136,544-154,423
Operating profit 75,27184,191187,885
Net finance costs -1316492,999
Share of associates and JVs -363-348347
Profit before tax 74,77784,492191,231
Income tax expense -16,591-16,827-40,299
Profit for the year 58,18667,665150,932
Profit attributable to owners 59,75868,837150,689
Balance Sheet
Item 201820192020
Cash and cash equivalents 216,015504,697877,578
Trade and bills receivables 107,42397,816101,693
Inventories 21,66322,82719,914
Total current assets 372,813655,5751,003,708
Total assets 472,500852,7891,210,139
Total current liabilities 249,156471,073675,718
Total liabilities 308,948559,410712,465
Total equity 163,552293,379497,674
Equity attributable to owners 166,510297,418501,703
Cash Flow Statement
Item 201820192020
Net cash from operating activities 144,585402,332408,279
Net cash from investing activities -2,062-103,035-7,276
Net cash from financing activities -61,827-11,304-23,333
Net increase in cash 80,696287,993377,670
Purchase of PP&E -35,938-39,779-41,285
Income Statement
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
First Day CloseHK$ 401.0
First Day OpenHK$ 400.0
First Day Change131.79%
First Day Volume14863200.0
First Day Turnover5878200000.0
Use of Proceeds
1、約39.9%用于為無錫市創美基地的建設提供資金; 2、約18.3%用于提升我們的研發能力以及為內部和合作研發項目提供資金; 3、約10.8%用于開發靈活及可擴展的智能信息技術系統以精簡及全面數字化我們運營的所有方面,并部署數據中間平臺; 4、約10.5%用于擴大我們的內部銷售團隊,并為銷售人員提供培訓課程以提高銷售效能和效率; 5、約9.6%用于為各種營銷及品牌推廣活動提供資金,以擴大用戶基礎并提升品牌形象; 6、約6.2%用于優化我們的醫學服務; 7、約4.7%用作營運資本及其他一般企業用途。

Underwriting Syndicate

Joint Sponsors (2)
GOLDMAN SACHS (ASIA) L.L.C. CE ACC536 中国国际金融香港证券有限公司 CE AEN894
Overall Coordinators (2)
GOLDMAN SACHS (ASIA) L.L.C. CE ACC536 中国国际金融香港证券有限公司 CE AEN894
Joint Bookrunners (2)
GOLDMAN SACHS (ASIA) L.L.C. CE ACC536 中国国际金融香港证券有限公司 CE AEN894
Joint Lead Managers (2)
GOLDMAN SACHS (ASIA) L.L.C. CE ACC536 中国国际金融香港证券有限公司 CE AEN894

Cornerstone Investors

This stock has no cornerstone investors.

Directors & Management

PositionChinese nameEnglish Name
Chairman馮岱—
Company Secretary朱凌波、朱卓婷—
No director data available.

Major Shareholders

Major Shareholders & Holdings松柏正畸技術有限公司持股60.3110%、天榮企業有限公司持股14.2680%、廣福環球有限公司持股7.1388%(緊隨全球發售完成後)
About this page

This page shows Angelalign (06699) prospectus details: offer price range, fundraise size, cornerstone investors, greenshoe, Pool A/B allocation and syndicate. For eligible IPOs it also provides a Stock Connect inclusion analysis, indicating the pathway and estimated timing for Southbound Connect admission; for A-share / US secondary listings, it additionally compares the other market's price, exchange rate and the H-share premium/discount. Data is parsed from the HKEX prospectus and related announcements. New to IPO subscription? See Hong Kong IPO Subscription 101.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect